XML 38 R24.htm IDEA: XBRL DOCUMENT
v3.25.1

Earnings Per Share ("EPS") | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Earnings Per Share (“EPS”) | Earnings Per Share (“EPS”) We present both basic and diluted EPS. We compute basic EPS by dividing net income available to common shareholders allocable to unrestricted common shares by the weighted average number of unrestricted common shares outstanding during the period after allocating undistributed earnings between common shareholders and participating securities under the two-class method. Our participating securities include restricted shares and PIUs and deferred share awards not previously settled by common share issuances. Our computation of diluted EPS is similar except that: >the denominator is increased to include: (1) the weighted average number of potential additional common shares that would have been outstanding if securities that are convertible into common shares were converted; and (2) the effect of dilutive potential common shares outstanding during the period attributable to redeemable noncontrolling interest and share-based compensation awards using the if-converted or treasury stock methods; and >the numerator is adjusted to add back any changes in income that would result from the assumed conversion into common shares that we add to the denominator. We compute diluted EPS using the treasury stock method for unvested restricted shares, TB-PIUs and deferred share awards and the if-converted method for exchangeable debt (including our 5.25% Notes), common units, redeemable noncontrolling interest, PB-PIUs and vested PIUs and deferred share awards not previously settled by common share issuances. Summaries of the numerator and denominator for purposes of basic and diluted EPS calculations are set forth below (in thousands, except per share data):
| For the Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Numerator |  |  |  |  |  |  |
Net income attributable to common shareholders | $ | 34,740 |  |  | $ | 32,609 |  |  |  |  |
Income attributable to share-based compensation awards for basic EPS | (167) |  |  | (150) |  |  |  |  |
Numerator for basic EPS on net income attributable to common shareholders | 34,573 |  |  | 32,459 |  |  |  |  |
Adjustment to income attributable to share-based compensation awards for diluted EPS | 24 |  |  | 21 |  |  |  |  |
Numerator for diluted EPS on net income attributable to common shareholders | $ | 34,597 |  |  | $ | 32,480 |  |  |  |  |
Denominator (all weighted averages) |  |  |  |  |  |  |
Denominator for basic EPS (common shares) | 112,383 |  |  | 112,231 |  |  |  |  |
Dilutive effect of share-based compensation awards | 643 |  |  | 509 |  |  |  |  |
Denominator for diluted EPS (common shares) | 113,026 |  |  | 112,740 |  |  |  |  |
Basic EPS attributable to common shareholders | $ | 0.31 |  |  | $ | 0.29 |  |  |  |  |
Diluted EPS attributable to common shareholders | $ | 0.31 |  |  | $ | 0.29 |  |  |  |  |
Our diluted EPS computations do not include the effects of the following securities since the conversions of such securities would increase diluted EPS for the respective periods (in thousands):
| Weighted Average Shares Excluded from Denominator
| For the Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Conversion of common units | 2,047 |  |  | 1,625 |  |  |  |  |
Conversion of redeemable noncontrolling interest | 873 |  |  | 947 |  |  |  |  |
The following securities were also excluded from the computation of diluted EPS because their effect was antidilutive: >weighted average restricted shares and deferred share awards of 471,000 and 429,000 for the three months ended March 31, 2025 and 2024, respectively; >weighted average TB-PIUs of 228,000 and 206,000 for the three months ended March 31, 2025 and 2024, respectively; and >weighted average vested PIUs of 188,000 for the three months ended March 31, 2024. Our 5.25% Notes issued in 2023 have an exchange settlement feature under which the principal amount of notes exchanged is payable in cash, with the remainder of the exchange obligation, if any, determined based on the exchange price per common share at the time of settlement, payable in cash, common shares or a combination thereof at our election. These notes did not affect our diluted EPS reported above since the weighted average closing price of our common shares for the three months ended March 31, 2025 and 2024 was less than the exchange price applicable to those periods.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration